| 000 | 01561 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517120248.0 | ||
| 264 | 0 | _c20170727 | |
| 008 | 201707s 0 0 eng d | ||
| 022 | _a1873-264X | ||
| 024 | 7 |
_a10.1016/j.jpba.2016.09.040 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShi, Fuguo | |
| 245 | 0 | 0 |
_aNQO1 and CYP450 reductase decrease the systemic exposure of rifampicin-quinone and mediate its redox cycle in rats. _h[electronic resource] |
| 260 |
_bJournal of pharmaceutical and biomedical analysis _cJan 2017 |
||
| 300 |
_a17-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCalibration |
| 650 | 0 | 4 | _aChromatography, Liquid |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xmetabolism |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLimit of Detection |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMass Spectrometry |
| 650 | 0 | 4 |
_aNAD(P)H Dehydrogenase (Quinone) _xmetabolism |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 | _aQuality Control |
| 650 | 0 | 4 |
_aQuinones _xchemistry |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 |
_aRifampin _xanalogs & derivatives |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aLi, Xiaobing | |
| 700 | 1 | _aPan, Hong | |
| 700 | 1 | _aDing, Li | |
| 773 | 0 |
_tJournal of pharmaceutical and biomedical analysis _gvol. 132 _gp. 17-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jpba.2016.09.040 _zAvailable from publisher's website |
| 999 |
_c26475445 _d26475445 |
||